P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.